1. Home
  2. STXS vs LFT Comparison

STXS vs LFT Comparison

Compare STXS & LFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • LFT
  • Stock Information
  • Founded
  • STXS 1990
  • LFT 2012
  • Country
  • STXS United States
  • LFT United States
  • Employees
  • STXS N/A
  • LFT N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • LFT Real Estate Investment Trusts
  • Sector
  • STXS Health Care
  • LFT Real Estate
  • Exchange
  • STXS Nasdaq
  • LFT Nasdaq
  • Market Cap
  • STXS 151.3M
  • LFT 125.6M
  • IPO Year
  • STXS 2004
  • LFT N/A
  • Fundamental
  • Price
  • STXS $2.11
  • LFT $2.50
  • Analyst Decision
  • STXS
  • LFT Hold
  • Analyst Count
  • STXS 0
  • LFT 2
  • Target Price
  • STXS N/A
  • LFT N/A
  • AVG Volume (30 Days)
  • STXS 224.8K
  • LFT 118.5K
  • Earning Date
  • STXS 05-12-2025
  • LFT 05-12-2025
  • Dividend Yield
  • STXS N/A
  • LFT 16.47%
  • EPS Growth
  • STXS N/A
  • LFT N/A
  • EPS
  • STXS N/A
  • LFT 0.20
  • Revenue
  • STXS $27,510,000.00
  • LFT $27,066,283.00
  • Revenue This Year
  • STXS $25.90
  • LFT $177.59
  • Revenue Next Year
  • STXS $60.57
  • LFT N/A
  • P/E Ratio
  • STXS N/A
  • LFT $12.51
  • Revenue Growth
  • STXS 1.50
  • LFT N/A
  • 52 Week Low
  • STXS $1.54
  • LFT $2.22
  • 52 Week High
  • STXS $2.72
  • LFT $2.84
  • Technical
  • Relative Strength Index (RSI)
  • STXS 57.13
  • LFT 48.03
  • Support Level
  • STXS $2.07
  • LFT $2.38
  • Resistance Level
  • STXS $2.17
  • LFT $2.55
  • Average True Range (ATR)
  • STXS 0.10
  • LFT 0.10
  • MACD
  • STXS -0.00
  • LFT 0.00
  • Stochastic Oscillator
  • STXS 80.03
  • LFT 54.29

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About LFT Lument Finance Trust Inc.

Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.

Share on Social Networks: